vs
太平洋生物科学（ASMB）与SOLESENCE, INC.（SLSN）财务数据对比。点击上方公司名可切换其他公司
SOLESENCE, INC.的季度营收约是太平洋生物科学的1.2倍（$12.5M vs $10.8M），SOLESENCE, INC.净利率更高（1.3% vs -85.2%，领先86.5%），太平洋生物科学同比增速更快（57.6% vs -0.7%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
ASMB vs SLSN — 直观对比
营收规模更大
SLSN
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出58.3%
-0.7%
净利率更高
SLSN
高出86.5%
-85.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $12.5M |
| 净利润 | $-9.2M | $163.0K |
| 毛利率 | — | 27.5% |
| 营业利润率 | -100.9% | 1.5% |
| 净利率 | -85.2% | 1.3% |
| 营收同比 | 57.6% | -0.7% |
| 净利润同比 | 4.3% | 129.2% |
| 每股收益（稀释后） | $-0.72 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBSLSN
| Q4 25 | — | $12.5M | ||
| Q3 25 | $10.8M | $14.6M | ||
| Q2 25 | $9.6M | $20.4M | ||
| Q1 25 | $9.4M | $14.6M | ||
| Q4 24 | $7.4M | $12.6M | ||
| Q3 24 | $6.8M | $16.9M | ||
| Q2 24 | $8.5M | $13.0M | ||
| Q1 24 | $5.8M | $9.9M |
净利润ASMBSLSN
| Q4 25 | — | $163.0K | ||
| Q3 25 | $-9.2M | $-1.1M | ||
| Q2 25 | $-10.2M | $2.7M | ||
| Q1 25 | $-8.8M | $80.0K | ||
| Q4 24 | — | $-559.0K | ||
| Q3 24 | $-9.6M | $3.0M | ||
| Q2 24 | $-11.2M | $856.0K | ||
| Q1 24 | $-9.1M | $893.0K |
毛利率ASMBSLSN
| Q4 25 | — | 27.5% | ||
| Q3 25 | — | 23.1% | ||
| Q2 25 | — | 28.9% | ||
| Q1 25 | — | 23.1% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 36.2% | ||
| Q2 24 | — | 28.7% | ||
| Q1 24 | — | 36.3% |
营业利润率ASMBSLSN
| Q4 25 | — | 1.5% | ||
| Q3 25 | -100.9% | -5.4% | ||
| Q2 25 | -115.2% | 9.4% | ||
| Q1 25 | -105.5% | 1.8% | ||
| Q4 24 | — | -1.8% | ||
| Q3 24 | -160.1% | 19.0% | ||
| Q2 24 | -143.0% | 8.0% | ||
| Q1 24 | -185.5% | 11.3% |
净利率ASMBSLSN
| Q4 25 | — | 1.3% | ||
| Q3 25 | -85.2% | -7.7% | ||
| Q2 25 | -105.9% | 13.1% | ||
| Q1 25 | -93.6% | 0.5% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | -140.4% | 18.1% | ||
| Q2 24 | -130.7% | 6.6% | ||
| Q1 24 | -156.9% | 9.0% |
每股收益（稀释后）ASMBSLSN
| Q4 25 | — | $0.00 | ||
| Q3 25 | $-0.72 | $-0.02 | ||
| Q2 25 | $-1.33 | $0.04 | ||
| Q1 25 | $-1.17 | $0.00 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-1.51 | $0.04 | ||
| Q2 24 | $-1.98 | $0.01 | ||
| Q1 24 | $-1.66 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $1.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $17.6M |
| 总资产 | $240.0M | $50.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBSLSN
| Q4 25 | — | $1.3M | ||
| Q3 25 | $22.5M | $429.0K | ||
| Q2 25 | $24.0M | $4.1M | ||
| Q1 25 | $23.4M | $1.8M | ||
| Q4 24 | $38.3M | $1.4M | ||
| Q3 24 | $28.5M | $2.9M | ||
| Q2 24 | $19.2M | $2.4M | ||
| Q1 24 | $18.7M | $2.0M |
股东权益ASMBSLSN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $182.7M | $17.2M | ||
| Q2 25 | $18.1M | $18.2M | ||
| Q1 25 | $27.1M | $15.2M | ||
| Q4 24 | $33.4M | $14.9M | ||
| Q3 24 | $26.0M | $15.2M | ||
| Q2 24 | $34.7M | $11.9M | ||
| Q1 24 | $32.6M | $5.0M |
总资产ASMBSLSN
| Q4 25 | — | $50.1M | ||
| Q3 25 | $240.0M | $54.0M | ||
| Q2 25 | $80.8M | $60.0M | ||
| Q1 25 | $99.0M | $57.0M | ||
| Q4 24 | $119.2M | $50.0M | ||
| Q3 24 | $100.3M | $48.0M | ||
| Q2 24 | $115.3M | $40.8M | ||
| Q1 24 | $119.9M | $38.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 11.16× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBSLSN
| Q4 25 | — | $1.8M | ||
| Q3 25 | $-15.1M | $-2.5M | ||
| Q2 25 | $-16.8M | $-654.0K | ||
| Q1 25 | $-23.4M | $-7.2M | ||
| Q4 24 | $-51.1M | $2.2M | ||
| Q3 24 | $-15.2M | $4.2M | ||
| Q2 24 | $-17.1M | $-565.0K | ||
| Q1 24 | $-18.4M | $-3.9M |
自由现金流ASMBSLSN
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | $-404.0K | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | $-17.1M | $-1.0M | ||
| Q1 24 | $-18.4M | $-3.9M |
自由现金流率ASMBSLSN
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | -3.2% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | -200.6% | -8.0% | ||
| Q1 24 | -317.7% | -39.9% |
资本支出强度ASMBSLSN
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | 20.6% | ||
| Q3 24 | 0.0% | 8.3% | ||
| Q2 24 | 0.2% | 3.7% | ||
| Q1 24 | 0.2% | 0.9% |
现金转化率ASMBSLSN
| Q4 25 | — | 11.16× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.25× | ||
| Q1 25 | — | -90.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.38× | ||
| Q2 24 | — | -0.66× | ||
| Q1 24 | — | -4.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
